KRYSTEXXA

pegloticase · Horizon Therapeutics

Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for KRYSTEXXA, covering 2010-09-14 to 2026-08-07. Get the full timeline:

Most recent: FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)